Methotrexate
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Pfizer
Overview
Methotrexate is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Methotrexate clinical trials
Explore related
Medical disclaimer. This page summarizes research about Methotrexate for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.